Skip to main content
. 2024 Dec 1;16(23):4034. doi: 10.3390/cancers16234034
AJCC American Joint Committee on Cancer
AUC Area under the curve
CBC Complete blood count
ccRCC Clear cell renal cell carcinoma
CRP C-reactive protein
CT Computed tomography
FDG-PET Fluorodeoxyglucose-positron emission tomography
H&E Hematoxylin and eosin
ICI Immune checkpoint inhibitor
LDH Lactate dehydrogenase
LPN Laparoscopic partial nephrectomy
LRN Laparoscopic radical nephrectomy
MRI Magnetic resonance imaging
NSS Nephron-sparing surgery
OPN Open partial nephrectomy
ORN Open radical nephrectomy
OS Overall survival
PD-1 Programmed death 1
PD-L1 Programmed death ligand 1
PFS Progression-free survival
PN Partial nephrectomy
PNS Paraneoplastic syndrome
RAPN Robotic-assisted partial nephrectomy
RARN Robotic-assisted radical nephrectomy
RCC Renal cell carcinoma
RN Radical nephrectomy
RNS RENAL nephrometry score
RR Relative risk
TKI Tyrosine kinase inhibitor
TMN Tumor, Node, and Metastasis
TSC Tuberous sclerosis complex
US Ultrasonography
VEGF Vascular endothelial growth factor
VHL Von Hippel–Lindau gene